CD8A and neoplasm: The anti-tumor process of tumor vaccines as follows: (1) Tumor-specific antigens are absorbed by antigen-presenting cells and further processed by DCs into short peptides that facilitate the presentation of MHC molecules, which are presented to initial CD8+ and CD4+ T cells by MHC I or MHC II, respectively.